Counts of positive, neutral, and negative news items. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
The items moving the net sentiment the most, by direction and influence.
Supreme Court Upholds Medicare Drug Price Negotiation, Dealing Setback to Bristol-Myers Squibb, Amgen, and AbbVie
Drug pricing / FDA / IRA · Medium influence · Long term
Amgen Recalls Nearly 1 Million Bottles of Heart Failure Drug
Direct news · Low influence · Short term
FDA Rejects Sobi Gout Drug Over Manufacturing Issues, Protecting Amgen Franchise
Direct news · Low influence · Short term
Macro, commodity, FX and regulatory forces that moved AMGN in this range, with the stories behind each.
Also monitored for AMGN (no news in this range): FDA approvals & trial outcomes.
Sign up free to track AMGN, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track AMGN for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
